Drug intelligence / Profile preview

EMUAID

Development stage
Unknown
Lead developer
Speer Laboratories
Administration
Topical
01

Overview

**EMUAID** is a Speer Laboratories topical first-aid ointment marketed in the United States as an unapproved homeopathic human OTC drug product. Its labeled active ingredient is **Argentum metallicum** at 10x, 20x, and 30x HPUS homeopathic dilutions; the product is intended for temporary relief of symptoms such as minor pain, inflammation, itching, redness, burning, and stinging associated with minor wounds, burns, rashes, insect bites, acne eruptions, eczema eruptions, and minor skin infections. The label describes topical antiseptic, analgesic, and anti-inflammatory purposes, but FDA labeling states that the homeopathic product has not been evaluated by FDA for safety or efficacy and that FDA is not aware of scientific evidence supporting homeopathy as effective. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07b160d3-107c-4c29-a38e-f343e5b3a714))

Brand names
EMUAID
Other names
EMUAID First Aid Ointment

Beyond the preview

Go deeper on EMUAID.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EMUAID.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call